Acurx Pharmaceuticals, Inc. (ACXP) Net income 2020–2025
Acurx Pharmaceuticals, Inc. (ACXP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.0MFY2025 · since FY2020: -$4.6M → -$8.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.0M | +43.5% |
| FY2024 | -$14.1M | +3.3% |
| FY2023 | -$14.6M | -20.5% |
| FY2022 | -$12.1M | +5.1% |
| FY2021 | -$12.7M | -177.1% |
| FY2020 | -$4.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACXP financial trends
ACXP RevenueACXP Net marginACXP Gross profitACXP Gross marginACXP Operating incomeACXP Operating marginACXP Operating cash flowACXP Free cash flowACXP Capital expendituresACXP Return on equityACXP Stock buybacksACXP Dividends paidACXP Total assetsACXP Total liabilitiesACXP Shareholders’ equityACXP overview →